Overview of the VEXAS Syndrome
A current systematic review in Rheumatology addresses the clinical features seen in the VEXAS syndrome.
Read ArticleA current systematic review in Rheumatology addresses the clinical features seen in the VEXAS syndrome.
Read ArticleFollowing the establishment of formal definitions for Difficult-to-Treat Rheumatoid Arthritis (D2T RA) by EULAR and Difficult-to-Manage axial Spondyloarthritis (D2M axSpA) by ASAS, the “Difficult” framework has now reached psoriatic arthritis (PsA).
Read ArticleThe diagnosis of axial spondyloarthritis (axSpA) is clinical, however, there are still unmet needs, particularly in the diagnosis of early disease and evaluation of disease activity and progression.
Read ArticleA single center study shows HLA-B27 testing is often performed by both by rheumatologists and nonrheumatologists for a wide array of reasons and often along w
A large multicenter cohort study of Relapsing Polychondritis (RP) describes the clinical manifestations and treatment approaches to this rare, heterogeneous, multisystem disease.
This article was originally published March 31, 2025, and is being shared again this week as part of our In Case You Missed It series. Enjoy!
It's easy to think that in our current world that we've done it all for rheumatoid arthritis, that there's nothing left to be done after b/tsDMARDs have become relatively widespread and accessible.
Read ArticleThis article was originally published February 13, 2025, and is being shared again this week as part of our In Case You Missed It series. Enjoy!
Read ArticleThis article was originally published April 7, 2025, and is being shared again this week as part of our In Case You Missed It series.
More effective treatments in patients with rheumatic diseases have resulted in less need for major surgery, yet a substantial number of RMD patients will undergo surgery often in the setting of disease-modifying anti-rheumatic drugs (DMARDs) use.
Read ArticleA comprehensive review in Rheumatology on intracranial giant cell arteritis (icGCA) stresses that GCA is both an intracranial and extracranial large vessel vasculitis, with the former having unique presentations, and outcomes.
Dr. Jack Cush reviews the news and journal reports from this past week - some obvious, other new thoughts and some - hmmm, reallly?
Read ArticleMease et al has published the results of a cohort study showing early initiation of disease-modifying antirheumatic drugs (DMARDs) in patients with psoriatic arthritis (PsA) resulted in better outcomes compared to late initiation.
This article was originally published March 17, 2025, and is being shared again this week as part of our In Case You Missed It series. Enjoy!
Dr. Jack Cush reviews the news and journal reports from last week on RheumNow.com
Read ArticleA pooled analysis of 25 randomized clinical trials affirms the safety of ixekizumab (IXE) when used to treat patients with psoriasis (PsO), psoriatic arthritis (PsA), or axial spondyloarthritis (axSpA).
Read ArticleAutoimmune hepatitis (AIH) is a chronic, progressive inflammatory liver disease driven by autoimmune mechanisms, characterized by elevated serum aminotransferases, hypergammaglobulinemia, and interface hepatitis on histology.
Read ArticleA large prospective cohort study found that interstitial lung disease (ILD) is associated with an increased risk of lung cancer.
Read ArticleBy downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.